DePuy Lawsuit Emphasizes High ASR Failure Rate
Lieff Cabraser attorneys Wendy Fleishman and Lexi Hazam have announced that George Evans of Remington, Virginia, and James Mechaley of Bakersfield, California have filed suit against DePuy Orthopaedics for injuries suffered from their faulty DePuy ASR hip implants.
Lexi Hazam summarized the charges Evans and Mechaley have brought against DePuy: “DePuy was aware its ASR hip implant was failing at a high rate, yet continued to manufacture and sell the product to unsuspecting physicians and patients.”
The complaint alleges a current failure rate of thirteen percent of all DePuy ASR hip implants. However, evidence indicates that the true failure rate may rise much higher than thirteen percent.
The New York Times recently reported that Dr. Art Sedrakyan, a researcher at Weill Cornell Medical College of Cornell University, used data collected in other countries to predict that “tens of thousands” of U.S. patients will experience device failure in the coming decade.
The National Joint Registry of England and Wales has found a forty nine percent failure rate within six years of ASR hip implantation. 40,000 U.S. patients received DePuy ASR hip implants before Johnson & Johnson’s 2010 recall – in the coming decade, many of these still-young devices may prematurely fail, and the U.S. may catch up to the British forty nine percent failure rate.
Related posts:
- Medtronic Heart Lead Recall Update: “[Sprint] Fidelis lead fracture rate is increasing exponentially with time”
- Congressmen Seek Review of Medical Device Regulation
- Pain Killers & Liver Failure: FDA Restricts Acetaminophen in Some Products
- Tens of Thousands of Heart Patients May Be at Risk from Defective Device
- Zimmer Hip Recall Lawsuits: Patients Seek Compensation For Injuries From Faulty Hip Implant
